Ovid Therapeutics (OVID) Intangibles (2016 - 2022)
Ovid Therapeutics (OVID) posted Intangibles of $244000.0 for Q1 2022, down 7.22% on a QoQ basis from $263000.0 in Q4 2021, and down 7.22% year-over-year from $263000.0 in Q1 2021.
Ovid Therapeutics (OVID) Intangibles (2016 - 2022) Analysis & Trends
Ovid Therapeutics' Intangibles history runs 7 years deep, the most recent figure standing at $244000.0 for Q1 2022.
- Quarterly Intangibles fell 7.22% year-over-year to $244000.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $244000.0 (down 7.22% YoY) and the FY2021 annual result came in at $263000.0, down 17.55% from the prior year.
- Intangibles was $244000.0 for Q1 2022 at Ovid Therapeutics, down from $263000.0 in the prior quarter.
- Across five years, Intangibles topped out at $467000.0 in Q4 2019 and bottomed at $160390.0 in Q1 2018.
- A 5-year average of $316341.2 and a median of $319000.0 in 2020 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2018 — Intangibles soared 234.71% — and 2021, when it plunged 45.43%.
- Ovid Therapeutics' Intangibles stood at $392000.0 in 2018, then gained by 19.13% to $467000.0 in 2019, then slumped by 31.69% to $319000.0 in 2020, then retreated by 17.55% to $263000.0 in 2021, then dropped by 7.22% to $244000.0 in 2022.
- Business Quant data shows OVID's Intangibles at $244000.0 in Q1 2022, $263000.0 in Q4 2021, and $197000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 11,640.44 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 30.30 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 61.68 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 55.80 Mn |
| 10 | Ovid Therapeutics | 118.66 Mn | -36.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 244,000.00 |
| Dec 31, 2021 | 263,000.00 |
| Sep 30, 2021 | 197,000.00 |
| Jun 30, 2021 | 227,000.00 |
| Mar 31, 2021 | 263,000.00 |
| Dec 31, 2020 | 319,000.00 |
| Sep 30, 2020 | 361,000.00 |
| Jun 30, 2020 | 376,000.00 |
| Mar 31, 2020 | 436,000.00 |
| Dec 31, 2019 | 467,000.00 |
| Sep 30, 2019 | 351,000.00 |
| Jun 30, 2019 | 271,000.00 |
| Mar 31, 2019 | 331,000.00 |
| Dec 31, 2018 | 392,000.00 |
| Sep 30, 2018 | 406,078.00 |
| Jun 30, 2018 | 313,333.00 |
| Mar 31, 2018 | 160,390.00 |
| Dec 31, 2017 | 124,194.00 |
| Sep 30, 2017 | 121,323.00 |
| Jun 30, 2017 | 131,100.00 |